Neratinib
Neratinib market is segmented by region (country), players, by Type and by Application. Players, ... Read More
Global and United States Lorlatinib Market Report & Forecast 2024-2031
1 Study Coverage
1.1 Lorlatinib Product Introduction
1.2 Global Lorlatinib Outlook 2017 VS 2022 VS 2028
1.2.1 Global Lorlatinib Sales in US$ Million for the Year 2017-2028
1.2.2 Global Lorlatinib Sales in Volume for the Year 2017-2028
1.3 United States Lorlatinib Outlook 2017 VS 2022 VS 2028
1.3.1 United States Lorlatinib Sales in US$ Million for the Year 2017-2028
1.3.2 United States Lorlatinib Sales in Volume for the Year 2017-2028
1.4 Lorlatinib Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Lorlatinib in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Lorlatinib Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Lorlatinib Market Dynamics
1.5.1 Lorlatinib Industry Trends
1.5.2 Lorlatinib Market Drivers
1.5.3 Lorlatinib Market Challenges
1.5.4 Lorlatinib Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Lorlatinib Market Segment by Type
2.1.1 Tables 25mg
2.1.2 Tables 100mg
2.2 Global Lorlatinib Market Size by Type
2.2.1 Global Lorlatinib Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Lorlatinib Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Lorlatinib Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Lorlatinib Market Size by Type
2.3.1 United States Lorlatinib Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Lorlatinib Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Lorlatinib Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Lorlatinib Market Segment by Application
3.1.1 Squamous Cell Carcinoma of NSCLC
3.1.2 Adenocarcinoma of NSCLC
3.1.3 Large Cell Carcinoma of NSCLC
3.2 Global Lorlatinib Market Size by Application
3.2.1 Global Lorlatinib Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Lorlatinib Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Lorlatinib Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Lorlatinib Market Size by Application
3.3.1 United States Lorlatinib Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Lorlatinib Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Lorlatinib Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Lorlatinib Competitor Landscape by Company
4.1 Global Lorlatinib Market Size by Company
4.1.1 Top Global Lorlatinib Manufacturers Ranked by Revenue (2021)
4.1.2 Global Lorlatinib Revenue by Manufacturer (2017-2022)
4.1.3 Global Lorlatinib Sales by Manufacturer (2017-2022)
4.1.4 Global Lorlatinib Price by Manufacturer (2017-2022)
4.2 Global Lorlatinib Concentration Ratio (CR)
4.2.1 Lorlatinib Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Lorlatinib in 2021
4.2.3 Global Lorlatinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Lorlatinib Manufacturing Base Distribution, Product Type
4.3.1 Global Lorlatinib Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Lorlatinib Product Type
4.3.3 Date of International Manufacturers Enter into Lorlatinib Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Lorlatinib Market Size by Company
4.5.1 Top Lorlatinib Players in United States, Ranked by Revenue (2021)
4.5.2 United States Lorlatinib Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Lorlatinib Sales by Players (2020, 2021 & 2022)
5 Global Lorlatinib Market Size by Region
5.1 Global Lorlatinib Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Lorlatinib Market Size in Volume by Region (2017-2028)
5.2.1 Global Lorlatinib Sales in Volume by Region: 2017-2022
5.2.2 Global Lorlatinib Sales in Volume Forecast by Region (2023-2028)
5.3 Global Lorlatinib Market Size in Value by Region (2017-2028)
5.3.1 Global Lorlatinib Sales in Value by Region: 2017-2022
5.3.2 Global Lorlatinib Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Lorlatinib Market Size YoY Growth 2017-2028
6.1.2 North America Lorlatinib Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Lorlatinib Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Lorlatinib Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Lorlatinib Market Size YoY Growth 2017-2028
6.3.2 Europe Lorlatinib Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Lorlatinib Market Size YoY Growth 2017-2028
6.4.2 Latin America Lorlatinib Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Lorlatinib Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Lorlatinib Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Corporation Information
7.1.2 Pfizer Description and Business Overview
7.1.3 Pfizer Lorlatinib Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Pfizer Lorlatinib Products Offered
7.1.5 Pfizer Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Lorlatinib Industry Chain Analysis
8.2 Lorlatinib Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Lorlatinib Distributors
8.3 Lorlatinib Production Mode & Process
8.4 Lorlatinib Sales and Marketing
8.4.1 Lorlatinib Sales Channels
8.4.2 Lorlatinib Distributors
8.5 Lorlatinib Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Lorlatinib CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Lorlatinib Market Trends
Table 3. Lorlatinib Market Drivers
Table 4. Lorlatinib Market Challenges
Table 5. Lorlatinib Market Restraints
Table 6. Global Lorlatinib Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Lorlatinib Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Lorlatinib Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Lorlatinib Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Lorlatinib Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Lorlatinib Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Lorlatinib Revenue Share by Manufacturer, 2017-2022
Table 13. Global Lorlatinib Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Lorlatinib Sales Share by Manufacturer, 2017-2022
Table 15. Global Lorlatinib Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Lorlatinib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Lorlatinib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lorlatinib as of 2021)
Table 18. Top Players of Lorlatinib in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Lorlatinib Product Type
Table 20. Date of International Manufacturers Enter into Lorlatinib Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Lorlatinib Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Lorlatinib Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Lorlatinib Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Lorlatinib Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Lorlatinib Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Lorlatinib Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Lorlatinib Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Lorlatinib Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Lorlatinib Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Lorlatinib Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Lorlatinib Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Lorlatinib Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Lorlatinib Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Lorlatinib Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Lorlatinib Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Lorlatinib Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Lorlatinib Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Lorlatinib Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Lorlatinib Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Lorlatinib Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Pfizer Corporation Information
Table 43. Pfizer Description and Business Overview
Table 44. Pfizer Lorlatinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. Pfizer Lorlatinib Product
Table 46. Pfizer Recent Development
Table 47. Key Raw Materials Lists
Table 48. Raw Materials Key Suppliers Lists
Table 49. Lorlatinib Customers List
Table 50. Lorlatinib Distributors List
Table 51. Research Programs/Design for This Report
Table 52. Key Data Information from Secondary Sources
Table 53. Key Data Information from Primary Sources
List of Figures
Figure 1. Lorlatinib Product Picture
Figure 2. Global Lorlatinib Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Lorlatinib Market Size 2017-2028 (US$ Million)
Figure 4. Global Lorlatinib Sales 2017-2028 (K Pcs)
Figure 5. United States Lorlatinib Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Lorlatinib Market Size 2017-2028 (US$ Million)
Figure 7. United States Lorlatinib Sales 2017-2028 (K Pcs)
Figure 8. United States Lorlatinib Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Lorlatinib Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Lorlatinib Report Years Considered
Figure 11. Product Picture of Tables 25mg
Figure 12. Product Picture of Tables 100mg
Figure 13. Global Lorlatinib Market Share by Type in 2022 & 2028
Figure 14. Global Lorlatinib Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Lorlatinib Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Lorlatinib Sales by Type (2017-2028) & (K Pcs)
Figure 17. Global Lorlatinib Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Lorlatinib Price by Type (2017-2028) & (USD/Pcs)
Figure 19. United States Lorlatinib Market Share by Type in 2022 & 2028
Figure 20. United States Lorlatinib Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Lorlatinib Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Lorlatinib Sales by Type (2017-2028) & (K Pcs)
Figure 23. United States Lorlatinib Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Lorlatinib Price by Type (2017-2028) & (USD/Pcs)
Figure 25. Product Picture of Squamous Cell Carcinoma of NSCLC
Figure 26. Product Picture of Adenocarcinoma of NSCLC
Figure 27. Product Picture of Large Cell Carcinoma of NSCLC
Figure 28. Global Lorlatinib Market Share by Application in 2022 & 2028
Figure 29. Global Lorlatinib Sales in Value by Application (2017-2028) & (US$ Million)
Figure 30. Global Lorlatinib Sales Market Share in Value by Application (2017-2028)
Figure 31. Global Lorlatinib Sales by Application (2017-2028) & (K Pcs)
Figure 32. Global Lorlatinib Sales Market Share in Volume by Application (2017-2028)
Figure 33. Global Lorlatinib Price by Application (2017-2028) & (USD/Pcs)
Figure 34. United States Lorlatinib Market Share by Application in 2022 & 2028
Figure 35. United States Lorlatinib Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. United States Lorlatinib Sales Market Share in Value by Application (2017-2028)
Figure 37. United States Lorlatinib Sales by Application (2017-2028) & (K Pcs)
Figure 38. United States Lorlatinib Sales Market Share in Volume by Application (2017-2028)
Figure 39. United States Lorlatinib Price by Application (2017-2028) & (USD/Pcs)
Figure 40. North America Lorlatinib Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 41. North America Lorlatinib Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 42. U.S. Lorlatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Canada Lorlatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Europe Lorlatinib Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 45. Europe Lorlatinib Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. Germany Lorlatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. France Lorlatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. U.K. Lorlatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Italy Lorlatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Russia Lorlatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Asia-Pacific Lorlatinib Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 52. Asia-Pacific Lorlatinib Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. China Lorlatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Japan Lorlatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. South Korea Lorlatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. India Lorlatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Australia Lorlatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Taiwan Lorlatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Indonesia Lorlatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Thailand Lorlatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Malaysia Lorlatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Philippines Lorlatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America Lorlatinib Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 64. Latin America Lorlatinib Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico Lorlatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil Lorlatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina Lorlatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Middle East & Africa Lorlatinib Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 69. Middle East & Africa Lorlatinib Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Turkey Lorlatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Saudi Arabia Lorlatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. U.A.E Lorlatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Lorlatinib Value Chain
Figure 74. Lorlatinib Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer